Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Genotype phenotype correlation in a pediatric population with antithrombin deficiency.

Kovac M, Mitic G, Djilas I, Kuzmanovic M, Serbic O, Lekovic D, Tomic B, Bereczky Z.

Eur J Pediatr. 2019 Jul 29. doi: 10.1007/s00431-019-03433-5. [Epub ahead of print]

PMID:
31359133
2.

A new ELISA method for the measurement of total α2-plasmin inhibitor level in human body fluids.

Teráz-Orosz A, Csapó A, Bagoly Z, Székely EG, Tóth E, Kovács B, Bereczky Z, Muszbek L, Katona É.

J Immunol Methods. 2019 Aug;471:27-33. doi: 10.1016/j.jim.2019.05.004. Epub 2019 May 24.

PMID:
31129263
3.

[Genetic diagnostics of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)].

Major T, Gindele R, Szabó Z, Jóni N, Kis Z, Bora L, Bárdossy P, Rácz T, Karosi T, Bereczky Z.

Orv Hetil. 2019 May;160(18):710-719. doi: 10.1556/650.2019.31380. Hungarian.

PMID:
31030535
4.

Inherited thrombophilia and the risk of myocardial infarction: current evidence and uncertainties.

Bereczky Z, Balogh L, Bagoly Z.

Kardiol Pol. 2019 Apr 18;77(4):419-429. doi: 10.33963/KP.14804. Epub 2019 Apr 25.

5.

[Multiple ischemic stroke in Osler-Rendu-Weber disease].

Salamon A, Faragó P, Németh VL, Szépfalusi N, Horváth E, Vass A, Bereczky Z, Tajti J, Vécsei L, Klivényi P, Zádori D.

Ideggyogy Sz. 2019 Jan 30;72(1-2):65-70. doi: 10.18071/isz.72.0065. Hungarian.

PMID:
30785249
6.

The Stratified Population Screening of Hereditary Hemorrhagic Telangiectasia.

Major T, Gindele R, Szabó Z, Kis Z, Bora L, Jóni N, Bárdossy P, Rácz T, Bereczky Z.

Pathol Oncol Res. 2019 Jan 26. doi: 10.1007/s12253-019-00602-7. [Epub ahead of print]

PMID:
30685840
7.

The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications.

Kovac M, Mitic G, Mikovic Z, Mandic V, Miljic P, Mitrovic M, Tomic B, Bereczky Z.

Thromb Res. 2019 Jan;173:12-19. doi: 10.1016/j.thromres.2018.11.006. Epub 2018 Nov 7.

PMID:
30458337
8.

Replacement of the L-iduronic acid unit of the anticoagulant pentasaccharide idraparinux by a 6-deoxy-L-talopyranose - Synthesis and conformational analysis.

Demeter F, Gyöngyösi T, Bereczky Z, Kövér KE, Herczeg M, Borbás A.

Sci Rep. 2018 Sep 13;8(1):13736. doi: 10.1038/s41598-018-31854-z.

9.

Low factor XIII levels after intravenous thrombolysis predict short-term mortality in ischemic stroke patients.

Székely EG, Czuriga-Kovács KR, Bereczky Z, Katona É, Mezei ZA, Nagy A, Tóth NK, Berényi E, Muszbek L, Csiba L, Bagoly Z.

Sci Rep. 2018 May 16;8(1):7662. doi: 10.1038/s41598-018-26025-z.

10.

Evaluation of endogenous thrombin potential among patients with antithrombin deficiency.

Kovac M, Mitic G, Lalic-Cosic S, Djordjevic V, Tomic B, Muszbek L, Bereczky Z.

Thromb Res. 2018 Jun;166:50-53. doi: 10.1016/j.thromres.2018.04.004. Epub 2018 Apr 7. No abstract available.

PMID:
29655003
11.

Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients.

Balogh L, Katona É, Mezei ZA, Kállai J, Gindele R, Édes I, Muszbek L, Papp Z, Bereczky Z.

Mol Cell Biochem. 2018 Nov;448(1-2):199-209. doi: 10.1007/s11010-018-3326-8. Epub 2018 Feb 26.

PMID:
29484525
12.

A decade-long clinical experience on the prophylactic use of activated prothrombin complex concentrate in acquired haemophilia A: a case series from a tertiary care centre.

Árokszállási A, Rázsó K, Ilonczai P, Oláh Z, Bereczky Z, Boda Z, Schlammadinger Á.

Blood Coagul Fibrinolysis. 2018 Apr;29(3):282-287. doi: 10.1097/MBC.0000000000000716.

PMID:
29474202
13.

Characteristics of platelet count and size and diagnostic accuracy of mean platelet volume in patients with venous thromboembolism. A systematic review and meta-analysis.

Kovács S, Csiki Z, Zsóri KS, Bereczky Z, Shemirani AH.

Platelets. 2019;30(2):139-147. doi: 10.1080/09537104.2017.1414175. Epub 2017 Dec 18.

PMID:
29252063
14.

[Laboratory aspects of novel oral anticoagulant treatment].

Bereczky Z, Oláh Z, Ajzner É, Kappelmayer J.

Orv Hetil. 2017 Dec;158(49):1930-1945. doi: 10.1556/650.2017.30928. Review. Hungarian.

PMID:
29199435
15.

Clinical and laboratory characteristics of antithrombin deficiencies: A large cohort study from a single diagnostic center.

Gindele R, Selmeczi A, Oláh Z, Ilonczai P, Pfliegler G, Marján E, Nemes L, Nagy Á, Losonczy H, Mitic G, Kovac M, Balogh G, Komáromi I, Schlammadinger Á, Rázsó K, Boda Z, Muszbek L, Bereczky Z.

Thromb Res. 2017 Dec;160:119-128. doi: 10.1016/j.thromres.2017.10.023. Epub 2017 Oct 31.

PMID:
29153735
16.

Plasminogen Activator Inhibitor Type 1: A Possible Novel Biomarker of Late Pituitary Dysfunction after Mild Traumatic Brain Injury.

Frendl I, Katko M, Galgoczi E, Boda J, Zsiros N, Nemeti Z, Bereczky Z, Hudak R, Kappelmayer J, Erdei A, Turchanyi B, Nagy EV.

J Neurotrauma. 2017 Dec 1;34(23):3238-3244. doi: 10.1089/neu.2017.5198. Epub 2017 Nov 1.

PMID:
28931364
17.

Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.

Mezei ZA, Katona É, Kállai J, Bereczky Z, Somodi L, Molnár É, Kovács B, Miklós T, Ajzner É, Muszbek L.

Thromb Res. 2017 Oct;158:93-97. doi: 10.1016/j.thromres.2017.08.018. Epub 2017 Aug 26.

PMID:
28865246
18.

Antithrombin Debrecen (p.Leu205Pro) - Clinical and molecular characterization of a novel mutation associated with severe thrombotic tendency.

Selmeczi A, Gindele R, Ilonczai P, Fekete A, Komáromi I, Schlammadinger Á, Rázsó K, Kovács KB, Bárdos H, Ádány R, Muszbek L, Bereczky Z, Boda Z, Oláh Z.

Thromb Res. 2017 Oct;158:1-7. doi: 10.1016/j.thromres.2017.07.023. Epub 2017 Jul 24.

PMID:
28783511
19.

Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.

Tóth NK, Csanádi Z, Hajas O, Kiss A, Nagy-Baló E, Kovács KB, Sarkady F, Muszbek L, Bereczky Z, Csiba L, Bagoly Z.

Biomed Res Int. 2017;2017:3678017. doi: 10.1155/2017/3678017. Epub 2017 Jun 21.

20.

Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism.

Mezei ZA, Katona É, Kállai J, Bereczky Z, Molnár É, Kovács B, Ajzner É, Bagoly Z, Miklós T, Muszbek L.

Thromb Res. 2016 Dec;148:101-106. doi: 10.1016/j.thromres.2016.10.025. Epub 2016 Oct 27.

PMID:
27821352
21.

Evidence for the founder effect of a novel ACVRL1 splice-site mutation in Hungarian hereditary hemorrhagic telangiectasia families.

Major T, Gindele R, Szabó Z, Alef T, Thiele B, Bora L, Kis Z, Bárdossy P, Rácz T, Havacs I, Bereczky Z.

Clin Genet. 2016 Nov;90(5):466-467. doi: 10.1111/cge.12806. Epub 2016 Jun 12. No abstract available.

PMID:
27291782
22.

Deficiencies of the Natural Anticoagulants - Novel Clinical Laboratory Aspects of Thrombophilia Testing.

Bereczky Z, Gindele R, Speker M, Kállai J.

EJIFCC. 2016 Apr 20;27(2):130-46. eCollection 2016 Apr.

23.

Early onset of abdominal venous thrombosis in a newborn with homozygous type II heparin-binding site antithrombin deficiency.

Kovac M, Mitic G, Jesic M, Djordjevic V, Muszbek L, Bereczky Z.

Blood Coagul Fibrinolysis. 2017 Apr;28(3):264-266. doi: 10.1097/MBC.0000000000000570.

PMID:
27214036
24.

Plasma homocysteine levels are related to medium-term venous graft degeneration in coronary artery bypass graft patients.

Balogh E, Maros T, Daragó A, Csapó K, Herceg B, Nyul B, Czuriga I, Bereczky Z, Édes I, Koszegi Z.

Anatol J Cardiol. 2016 Nov;16(11):868-873. doi: 10.14744/AnatolJCardiol.2016.6738. Epub 2016 Apr 25.

25.

The lack of aspirin resistance in patients with coronary artery disease.

Homoródi N, Kovács EG, Leé S, Katona É, Shemirani AH, Haramura G, Balogh L, Bereczky Z, Szőke G, Péterfy H, Kiss RG, Édes I, Muszbek L.

J Transl Med. 2016 Mar 15;14:74. doi: 10.1186/s12967-016-0827-7.

26.

Pregnancy related stroke in the setting of homozygous type-II HBS antithrombin deficiency.

Kovac M, Mitic G, Mikovic Z, Mandic V, Djordjevic V, Muszbek L, Bereczky Z.

Thromb Res. 2016 Mar;139:111-3. doi: 10.1016/j.thromres.2016.01.018. Epub 2016 Jan 27. No abstract available.

PMID:
26916305
27.

Evaluation of flow cytometric HIT assays in relation to an IgG-Specific immunoassay and clinical outcome.

Kerényi A, Beke Debreceni I, Oláh Z, Ilonczai P, Bereczky Z, Nagy B Jr, Muszbek L, Kappelmayer J.

Cytometry B Clin Cytom. 2017 Sep;92(5):389-397. doi: 10.1002/cyto.b.21362. Epub 2016 Mar 11.

28.

Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort.

Gindele R, Oláh Z, Ilonczai P, Speker M, Udvari Á, Selmeczi A, Pfliegler G, Marján E, Kovács B, Boda Z, Muszbek L, Bereczky Z.

J Thromb Haemost. 2016 Apr;14(4):704-15. doi: 10.1111/jth.13252. Epub 2016 Feb 16.

29.

Alloantibody developed in a factor XIII A subunit deficient patient during substitution therapy; characterization of the antibody.

Pénzes K, Vezina C, Bereczky Z, Katona É, Kun M, Muszbek L, Rivard GE.

Haemophilia. 2016 Mar;22(2):268-275. doi: 10.1111/hae.12786. Epub 2015 Aug 7.

PMID:
26249653
30.

Management and outcome of pregnancies in women with antithrombin deficiency: a single-center experience and review of literature.

Ilonczai P, Oláh Z, Selmeczi A, Kerényi A, Bereczky Z, Póka R, Schlammadinger Á, Boda Z.

Blood Coagul Fibrinolysis. 2015 Oct;26(7):798-804. doi: 10.1097/MBC.0000000000000348. Review.

PMID:
26226254
31.

Molecular characterization of p.Asp77Gly and the novel p.Ala163Val and p.Ala163Glu mutations causing protein C deficiency.

Kovács KB, Pataki I, Bárdos H, Fekete A, Pfliegler G, Haramura G, Gindele R, Komáromi I, Balla G, Ádány R, Muszbek L, Bereczky Z.

Thromb Res. 2015 Apr;135(4):718-26. doi: 10.1016/j.thromres.2015.01.011. Epub 2015 Jan 15.

PMID:
25618265
32.

Factor XIII B subunit polymorphisms and the risk of coronary artery disease.

Mezei ZA, Bereczky Z, Katona É, Gindele R, Balogh E, Fiatal S, Balogh L, Czuriga I, Ádány R, Édes I, Muszbek L.

Int J Mol Sci. 2015 Jan 6;16(1):1143-59. doi: 10.3390/ijms16011143. Erratum in: Int J Mol Sci. 2015;16(4):7375-6.

33.

Dynamic properties of the native free antithrombin from molecular dynamics simulations: computational evidence for solvent- exposed Arg393 side chain.

Tóth L, Fekete A, Balogh G, Bereczky Z, Komáromi I.

J Biomol Struct Dyn. 2015 Sep;33(9):2023-36. doi: 10.1080/07391102.2014.986525. Epub 2014 Dec 8.

PMID:
25483839
34.

The use of recombinant factor XIII in a major bleeding episode of a patient with congenital factor XIII deficiency--the first experience.

Árokszállási A, Kerényi A, Katona É, Bereczky Z, Muszbek L, Boda Z, Schlammadinger Á.

Haemophilia. 2015 Jan;21(1):e118-21. doi: 10.1111/hae.12591. Epub 2014 Dec 4. No abstract available.

PMID:
25471755
35.

Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies.

Kovács B, Bereczky Z, Selmeczi A, Gindele R, Oláh Z, Kerényi A, Boda Z, Muszbek L.

Clin Chem Lab Med. 2014 Dec;52(12):1797-806. doi: 10.1515/cclm-2014-0246.

PMID:
24968404
36.

Poor pregnancy outcome in women with homozygous type-II HBS antithrombin deficiency.

Kovac M, Mitic G, Miljic P, Mikovic Z, Mandic V, Djordjevic V, Radojkovic D, Bereczky Z, Muszbek L.

Thromb Res. 2014 Jun;133(6):1158-60. doi: 10.1016/j.thromres.2014.03.025. Epub 2014 Mar 11. No abstract available.

PMID:
24702813
37.

Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke.

Shemirani AH, Antalfi B, Pongrácz E, Mezei ZA, Bereczky Z, Csiki Z.

Blood Coagul Fibrinolysis. 2014 Jun;25(4):364-8. doi: 10.1097/MBC.0000000000000055.

PMID:
24686102
38.

Evaluation of laboratory methods routinely used to detect the effect of aspirin against new reference methods.

Kovács EG, Katona É, Bereczky Z, Homoródi N, Balogh L, Tóth E, Péterfy H, Kiss RG, Édes I, Muszbek L.

Thromb Res. 2014 May;133(5):811-6. doi: 10.1016/j.thromres.2013.10.008. Epub 2013 Oct 16.

39.

The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency.

Kovács B, Bereczky Z, Oláh Z, Gindele R, Kerényi A, Selmeczi A, Boda Z, Muszbek L.

Am J Clin Pathol. 2013 Nov;140(5):675-9. doi: 10.1309/AJCPVY4Z9XZMFOTH.

PMID:
24124146
40.

Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations.

Katona É, Muszbek L, Devreese K, Kovács KB, Bereczky Z, Jonkers M, Shemirani AH, Mondelaers V, Ermens AA.

Haemophilia. 2014 Jan;20(1):114-20. doi: 10.1111/hae.12267. Epub 2013 Oct 1.

PMID:
24118344
41.

Direct thrombin inhibitors and factor xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant.

Olah Z, Szarvas M, Bereczky Z, Kerenyi A, Kappelmayer J, Boda Z.

Arch Pathol Lab Med. 2013 Jul;137(7):967-73. doi: 10.5858/arpa.2012-0236-OA.

PMID:
23808469
42.

New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals.

Kovács EG, Katona E, Bereczky Z, Homoródi N, Balogh L, Tóth E, Péterfy H, Kiss RG, Edes I, Muszbek L.

Thromb Res. 2013 Apr;131(4):320-4. doi: 10.1016/j.thromres.2013.01.033. Epub 2013 Feb 17.

PMID:
23422285
43.

Vitamin B12 level in peripheral arterial disease.

Zsóri KS, Csiki Z, Katona É, Bereczky Z, Shemirani AH.

J Thromb Thrombolysis. 2013 Jul;36(1):77-83. doi: 10.1007/s11239-012-0807-6.

PMID:
22983814
44.

Acquired haemophilia: an often overlooked cause of bleeding - experience from a Hungarian tertiary care centre.

Arokszállási Á, Ilonczai P, Rázsó K, Oláh Z, Bereczky Z, Boda Z, Schlammadinger A.

Blood Coagul Fibrinolysis. 2012 Oct;23(7):584-9.

PMID:
22885762
45.

Synthesis and anticoagulant activity of bioisosteric sulfonic-Acid analogues of the antithrombin-binding pentasaccharide domain of heparin.

Herczeg M, Lázár L, Bereczky Z, Kövér KE, Timári I, Kappelmayer J, Lipták A, Antus S, Borbás A.

Chemistry. 2012 Aug 20;18(34):10643-52. doi: 10.1002/chem.201201041. Epub 2012 Jul 10.

PMID:
22782535
46.

No indication of strict host associations in a widespread mycoparasite: grapevine powdery mildew (Erysiphe necator) is attacked by phylogenetically distant Ampelomyces strains in the field.

Pintye A, Bereczky Z, Kovács GM, Nagy LG, Xu X, Legler SE, Váczy Z, Váczy KZ, Caffi T, Rossi V, Kiss L.

Phytopathology. 2012 Jul;102(7):707-16. doi: 10.1094/PHYTO-10-11-0270.

47.

Recurrent arterial thrombosis associated with the antithrombin basel variant and elevated lipoprotein(a) plasma level in an adolescent patient.

Szilágyi S, Péter A, Magyar MT, Balogh S, Bereczky Z.

J Pediatr Hematol Oncol. 2012 May;34(4):276-9. doi: 10.1097/MPH.0b013e3182331ecd.

PMID:
22134617
48.

[Accessibility of special clinical laboratory tests in Hungary].

Kappelmayer J, Antal C, Bereczky Z.

Orv Hetil. 2011 Dec 18;152(51):2056-62. doi: 10.1556/OH.2011.29225. Hungarian.

PMID:
22130203
49.

Coagulation: cascade!

Olah Z, Bereczky Z, Szarvas M, Boda Z.

Lancet. 2011 Aug 20;378(9792):740. doi: 10.1016/S0140-6736(11)60875-1. No abstract available.

PMID:
21856488
50.

Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study.

Balogh E, Bereczky Z, Katona E, Koszegi Z, Edes I, Muszbek L, Czuriga I.

Thromb Res. 2012 Feb;129(2):133-8. doi: 10.1016/j.thromres.2011.07.001. Epub 2011 Jul 30.

PMID:
21803402

Supplemental Content

Loading ...
Support Center